InterMune engages in the research, development and commercialization of therapies in pulmonology and orphan fibrotic diseases.
Business Model:
Revenue: $300M
Employees: 201-500
Address: 3280 Bayshore Blvd
City: Brisbane
State: CA
Zip: 94005
Country: US
InterMune engages in the research, development and commercialization of therapies in pulmonology and orphan fibrotic diseases.
Contact Phone:
+14154662200
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
3/31/2000
Ticker Symbol:
ITMN
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2011 | Post-IPO Equity | 1 | - |
New Enterprise Associates New Enterprise Associates |
1/1999 | Venture Round | 1 | - |
Sofinnova Investments Sofinnova Investments |
3/2000 | IPO | $125M |
|
1/2011 | Post-IPO Equity | 1 | - |
New Enterprise Associates New Enterprise Associates |
1/1999 | Venture Round | 1 | - |
Sofinnova Investments Sofinnova Investments |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|